Obesity and biliary tract cancers: Changing epidemiology. Transarterial chemoembolization (TACE) combined with camrelizumab and apatinib versus TACE alone in the treatment of unresectable ...

A global comparative study on real-world clinical and genomic differences in advanced biliary tract cancer. Extra-hepatic (ehCCA) and intra-hepatic cholangiocarcinomas (iCCA): A genomic landscape ...

Scientific Advisory Board formed with internationally recognized liver and biliary tract cancer physicians to support the advancement of ...

Too much processed meat and not enough fruits and whole grains are the leading risk factors for diet-related GI cancers.

Compass Therapeutics Inc. (CMPX) stock soared to a 52-week high, reaching $3.14, marking a significant milestone for the biopharmaceutical company. With a market capitalization of $388 million, the ...

MSD’s PD-1 inhibitor Keytruda has been approved by the FDA as a treatment for locally advanced unresectable or metastatic biliary tract cancer (BTC) in combination with chemotherapy, the first ...

Albay is home to the first Endoscopy Unit with Endoscopic Ultrasound (EUS) in Bicol Region, Southern Luzon and Visayas. EUS ...

Everybody's poop will vary slightly. However, the ideal stool is smooth, easy to pass and brown. Healthy poops shouldn't take ...

No significant differences were observed for oesophagus, biliary tract and small intestine cancers.37 These findings emphasise a possible carcinogenic role for MASLD that is independent of obesity, ...

Background: The purpose of the present study was to define the differential diagnostic markers of benign and malignant bile duct strictures without demonstrable mass on ultrasonography (US ...